Antitumoral effect of local injection of TLR-9 agonist emulsified in Lipiodol with systemic anti-PD-1 in a murine model of colorectal carcinomaFRONTIERS IN IMMUNOLOGYIF5.92024-01-160OAAI
Evaluation of gadolinium-based contrast agents in pregnant CD-1 mice and subsequent in utero exposure of the developing offspring, including behavioral evaluationsBIRTH DEFECTS RESEARCHIF1.62023-12-290OAAI
Evaluation of gadolinium-based contrast agents in juvenile CD-1 mice including behavioral evaluationsBIRTH DEFECTS RESEARCHIF1.62023-12-290OAAI
Preclinical Safety Assessment of Gadopiclenol: A High-Relaxivity Macrocyclic Gadolinium-Based MRI Contrast AgentINVESTIGATIVE RADIOLOGYIF82023-11-035OAAI
Physicochemical and Pharmacokinetic Profiles of Gadopiclenol A New Macrocyclic Gadolinium Chelate With High T1 RelaxivityINVESTIGATIVE RADIOLOGYIF82019-04-0588OAAI
Does Age Interfere With Gadolinium Toxicity and Presence in Brain and Bone Tissues? A Comparative Gadoterate Versus Gadodiamide Study in Juvenile and Adult RatsINVESTIGATIVE RADIOLOGYIF82019-02-0132OAAI
Methodological Aspects for Preclinical Evaluation of Gadolinium Presence in Brain Tissue Critical Appraisal and Suggestions for Harmonization-A Joint InitiativeINVESTIGATIVE RADIOLOGYIF82018-09-0142OAAI
Multimodal Imaging Study of Gadolinium Presence in Rat Cerebellum Differences Between Gd Chelates, Presence in the Virchow-Robin Space, Association With Lipofuscin, and Hypotheses About Distribution PathwayINVESTIGATIVE RADIOLOGYIF82018-09-0115OAAI
Gadolinium Retention, Brain T1 Hyperintensity, and Endogenous Metals A Comparative Study of Macrocyclic Versus Linear Gadolinium Chelates in Renally Sensitized RatsINVESTIGATIVE RADIOLOGYIF82018-06-0160OAAI
Region of Interest Selection in Nonclinical Studies of Accumulated Gadolinium-based Contrast Agent-induced T1 Hyper-intensity in Deep Cerebellar NucleiRADIOLOGYIF15.22018-04-014PREAI
Moderate Renal Failure Accentuates T1 Signal Enhancement in the Deep Cerebellar Nuclei of Gadodiamide-Treated RatsINVESTIGATIVE RADIOLOGYIF82017-05-0141OAAI
Non-clinical safety assessment of gadoterate meglumine (Dotarem®) in neonatal and juvenile ratsREGULATORY TOXICOLOGY AND PHARMACOLOGYIF3.52015-12-0115PREAI
T1-Weighted Hypersignal in the Deep Cerebellar Nuclei After Repeated Administrations of Gadolinium-Based Contrast Agents in Healthy Rats Difference Between Linear and Macrocyclic AgentsINVESTIGATIVE RADIOLOGYIF82015-08-01228OAAI
Distribution profile of gadolinium in gadolinium chelate-treated renally-impaired rats: Role of pharmaceutical formulationEUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCESIF4.72015-05-0111PREAI
Safety profiles of gadolinium chelates in juvenile rats differ according to the risk of dissociationREPRODUCTIVE TOXICOLOGYIF2.82014-12-016PREAI
The role of gadolinium chelates in the mechanism of nephrogenic systemic fibrosis: A critical updateCRITICAL REVIEWS IN TOXICOLOGYIF4.12014-09-2689PREAI
Nephrogenic Systemic Fibrosis-Like Effects of Magnetic Resonance Imaging Contrast Agents in Rats with Adenine-Induced Renal FailureTOXICOLOGICAL SCIENCESIF4.12012-09-1222OAAI
Hyperphosphataemia sensitizes renally impaired rats to the profibrotic effects of gadodiamideBRITISH JOURNAL OF PHARMACOLOGYIF7.72012-01-2618OA
Gadolinium Contrast Agent Associated Stimulation of Human Fibroblast Collagen Production钆造影剂相关刺激人成纤维细胞胶原生成INVESTIGATIVE RADIOLOGYIF82011-11-0122PREAI
Comparative In Vivo Dissociation of Gadolinium Chelates in Renally Impaired Rats A Relaxometry StudyINVESTIGATIVE RADIOLOGYIF82011-05-0160PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向